Key facts
- This page summarizes William E. Kennard's Form 4 filing for METLIFE INC (MET).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Apr 2022, 16:13.
William E. Kennard - 01 Apr 2022 Form 4 Insider Report for METLIFE INC (MET)
- Reporting relationship
- Director
- Issuer ticker
- MET
- Reported as of
- 01 Apr 2022
- Net transaction value
- +$37,506
- SEC form
- 4
- Accepted by SEC
- 05 Apr 2022, 16:13:59 UTC
- Prior SEC filing
- 16 Mar 2022
- Next SEC filing
- 20 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anna Nazarenko, Authorized Signer
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William E. Kennard filed Form 4 for METLIFE INC (MET) on 05 Apr 2022.
Change
- Previous filing in this sequence was filed on 16 Mar 2022.
- Current net transaction value: +$37,506.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MET
transaction
Common Stock
Award
- Transaction value
- $37,506
- Shares
- +532
- Change %
- +1.7%
- Price
- $70.50
- Shares after
- 31,850
- Date
- 01 Apr 2022
- Ownership
- Direct
- Footnotes
- F1
MET
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10
- Date
- 01 Apr 2022
- Ownership
- By the MetLife Policyholder Trust
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.
Footnote F2
Shares held in trust under the MetLife Policyholder Trust established to hold shares of MetLife, Inc. common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.